Vincristine sulfate

• Supplier: R&D Systems
• Catalog: 1257
• Prices: $149.00, $629.00
• Sizes: 10 mg, 50 mg
• Cas Number: 2068-78-2
• Chemical Name: 22-Oxovincaleukoblastine
• Formula: C46H56N4O10.H2SO4
• Molecular Weight: 923.04
• Purity: >96%

Product References

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- - The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1-

Zhang H, Patel A, Wang YJ, Zhang YK, Kathawala RJ, Qiu LH, Patel BA, Huang LH, Shukla S, Yang DH, Ambudkar SV, Fu LW, Chen ZS. Mol Cancer Ther. 2017 Jun;16(6):1021-1030.

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a - Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a

Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. Nat Commun. 2015 Feb 11;6:6139.

Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor - Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor

Knutson SK, Warholic NM, Johnston LD, Klaus CR, Wigle TJ, Iwanowicz D, Littlefield BA, Porter-Scott M, Smith JJ, Moyer MP, Copeland RA, Pollock RM, Kuntz KW, Raimondi A, Keilhack H. PLoS One. 2014 Dec 10;9(12):e111840.

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate - Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate

Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R, Melcher A, Prestwich R, Harrington KJ, Morgan R, Pandha HS. BMC Cancer. 2011 Jun 6;11:221.